Table 2. Panel of cell lines used for in vitro experiments.
| Cell Line | MLL status | Disease | Supplier | Authenticationa |
|---|---|---|---|---|
| PER-485 | t(4;11) | Infant ALL | Kees UR et al. Mol Cancer Ther 2003 | STR profiling 22/03/2016 |
| PER-490 | t(4;11) | Infant ALL | Kees UR et al. Mol Cancer Ther 2003 | STR profiling 22/03/2016 |
| PER-703A | t(1;11) | Infant ALL | Kees UR et al. Mol Cancer Ther 2003 | STR profiling 22/03/2016 |
| PER-785A | t(4;11) | Infant ALL | Kees UR et al. Mol Cancer Ther 2003 | STR profiling 22/03/2016 |
| PER-826A | complex t(11;19) | Infant ALL | Kees UR et al. Mol Cancer Ther 2003 | STR profiling 22/03/2016 |
| MV4;11 | t(4;11) | Childhood AML | ATCC | STR profiling 05/07/2013 |
| RS4;11 | t(4;11) | Pre-B cell ALL | ATCC | STR profiling 22/03/2016 |
| SEMK2 | t(4;11) | Pre-B cell childhood ALL | ATCC | STR profiling 05/07/2013 |
| MOLM-13 | t(9;11) | AML | R D'Andrea, IMVS, South Australia, Australia | STR profiling 15/08/2015 |
| THP-1 | t(9;11) | Infant AML | W Jessup, Centre for Vascular Research, NSW, Australia | STR profiling 22/03/2016 |
| KOPN-8 | t(11;19) | Infant pre-B ALL | DSMZ | STR profiling 22/03/2016 |
| U937 | MLL-wt CALM-AF10 | AML derived from histiocytic lymphoma | ATCC | STR profiling 17/06/2014 |
| KP-MO-TS | MLL-wt CALM-AF10 | AML | Imamura T [77] | NAb |
| Loucy | MLL-wt SET-NUP214 | T-cell ALL | ATCC | STR profiling 22/03/2016 |
| KG-1 | MLL-wt | AML | ATCC | STR profiling 22/03/2016 |
| Kasumi-1 | MLL-wt | AML | ATCC | STR profiling 22/03/2016 |
| REH | MLL-wt | Pre-B cell ALL | ATCC | STR profiling 22/03/2016 |
| CEM | MLL-wt | T-cell ALL | ATCC | STR profiling 09/05/2013 |
| Jurkat | MLL-wt | Childhood T-cell ALL | ATCC | STR profiling 22/03/2016 |
| K562 | MLL-wt | CML | ATCC | STR profiling 22/03/2016 |
| Hal-01 | MLL-wt | ALL | A Thomas, Dana-Farber Cancer Institute, Massachusetts, USA | STR profiling 22/03/2016 |
| UOC-B1 | MLL-wt | Promyelocytic leukemia | A Thomas, Dana-Farber Cancer Institute, Massachusetts, USA | STR profiling 22/03/2016 |
| NB4 | MLL-wt | Acute promyelocytic leukemia | ATCC | STR profiling 22/03/2016 |
| Calu-6 | MLL-wt | Lung carcinoma | ATCC | STR profiling 22/03/2016 |
| MCF-7 | MLL-wt | Breast adenocarcinoma | ATCC | STR profiling 22/03/2016 |
| HeLa | MLL-wt | Adenocarcinoma | ATCC | STR profiling 31/07/2014 |
| BE(2)-C | MLL-wt | Neuroblastoma | J Biedler, Memorial Sloan-Kettering Cancer Centre, NY, USA | STR profiling 04/12/2012 |
| HSF | MLL-wt | Primary skin fibroblast cells | ATCC | STR profiling 22/03/2016 |
| MRC5 | MLL-wt | Lung fibroblast | ATCC | STR profiling 04/02/2014 |
| MCF10a | MLL-wt | Epithelial cell | ATCC | STR profiling 22/03/2016 |
a
Method and date of authentication
b
Cells up to ten passages from the original stock were used for experiments